If you are following Roche's attempt to take over Illumina, GenomeWeb has posted a new article that includes the comment:
and this one:
No kidding?!? It is called the GS-FLX! Why not pump that $5.7 billion into that platform instead of attempting to acquire a competitor! Instead of just letting it wither, like you are doing now...
--
Phillip
Roche Chairman Franz Humer today said that the firm has "other options" if its bid to acquire Illumina fails.
"Illumina is not the only gene sequencing company, and there are other companies making quantum leaps in this field. Roche is also working on gene sequencing technologies of its own."
--
Phillip
Comment